The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 42 | 576.4x | 20.1x | Near average | |
Growth | 69 | 6.5% | 5.6% | Above average | |
Quality | 49 | 5.1% | 7.6% | Near average | |
Safety | 66 | -0.7x | 0.4x | Near average | |
Capital Return | 92 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Mesa Laboratories, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Mesa Laboratories, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
MLAB stock shows a state of stagnation in analyst estimates, as the target price remained stable at 94 dollars without any change during the periods (last 1, 7, 30 days). Interestingly, there is a negative gap between the current target price (94 dollars) and the actual trading price (108.64 dollars), indicating that the stock is trading at a premium exceeding analyst estimates by approximately 13.5%, amid a complete absence of opinion dispersion given that only one analyst is currently covering the stock.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.